Drug Shortage Report for RESTASIS MULTIDOSE

Last updated on 2025-04-05 History
Report ID 239176
Drug Identification Number 02476835
Brand name RESTASIS MULTIDOSE
Common or Proper name Restasis Multidose
Company Name ABBVIE CORPORATION
Market Status MARKETED
Active Ingredient(s) CYCLOSPORINE
Strength(s) 0.05%
Dosage form(s) EMULSION
Route of administration OPHTHALMIC OPHTHALMIC
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 7mL
ATC code S01XA
ATC description OTHER OPHTHALMOLOGICALS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2024-10-11
Actual start date
Estimated end date 2025-04-11
Actual end date 2025-04-04
Shortage status Resolved
Updated date 2025-04-05
Company comments Manufacturing delay
Health Canada comments
Tier 3 Status No
Contact Address 8401 TRANS-CANADA HIGHWAY
SAINT-LAURENT, QUEBEC
CANADA H4S 1Z1
Company contact information Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2025-04-05 English Compare
v9 2025-04-04 French Compare
v8 2025-04-04 English Compare
v7 2025-02-12 French Compare
v6 2025-02-12 English Compare
v5 2024-10-29 French Compare
v4 2024-10-29 English Compare
v3 2024-10-12 English Compare
v2 2024-10-03 French Compare
v1 2024-10-03 English Compare

Showing 1 to 10 of 10